IRMD (iRadimed Corporation) Stock Analysis - Community

iRadimed Corporation (IRMD) is a publicly traded Healthcare sector company. As of May 21, 2026, IRMD trades at $90.40 with a market cap of $1.13B and a P/E ratio of 47.84. IRMD moved +1.82% today. Year to date, IRMD is -8.04%; over the trailing twelve months it is +69.64%. Its 52-week range spans $46.86 to $107.90. Analyst consensus is buy with an average price target of $116.00. Rallies surfaces IRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade IRMD?

Rallies community data for IRMD shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

IRMD Key Metrics

Key financial metrics for IRMD
MetricValue
Price$90.40
Market Cap$1.13B
P/E Ratio47.84
EPS$1.86
Dividend Yield0.20%
52-Week High$107.90
52-Week Low$46.86
Volume13
Avg Volume0
Revenue (TTM)$86.28M
Net Income$23.61M
Gross Margin76.83%

Latest IRMD News

Recent IRMD Insider Trades

  • Susi Roger E. sold 653 (~$56.90K) on May 19, 2026.
  • Susi Roger E. sold 1.84K (~$162.27K) on May 19, 2026.
  • Susi Roger E. sold 6 (~$531.9) on May 19, 2026.

IRMD Analyst Consensus

1 analysts cover IRMD: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $116.00.

Common questions about IRMD

How does the Rallies community trade IRMD?
Rallies community data for IRMD shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for IRMD?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for IRMD when enough community data is available.
Is IRMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IRMD. It does not provide personalized investment advice.
IRMD

IRMD